封面
市場調查報告書
商品編碼
1518909

2023-2029 年全球生命科學設備和研究工具透過自動化推動變革性成長

Life Science Instrumentation and Research Tools Driving Transformational Growth through Automation-Global, 2023-2029

出版日期: | 出版商: Frost & Sullivan | 英文 104 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

學術界實驗室預算的穩定增加促進創新

本研究分析了生命科學設備和研究工具產業,涵蓋實驗室使用的化學品、消耗品、設備、試劑、供應商和 IT 解決方案。預計 2023 年至 2029 年,全球生命科學設備和研究工具市場將穩定成長,並實現重大收益里程碑,其中實驗室自動化和軟體解決方案是主要驅動力。隨著生命科學研究成本的上升和預算的限制,傳統的器材與設備銷售方式被證明效率低。迫切需要新的經營模式,無需購買所有設備即可獲得新技術。此外,先進顯微鏡、基因編輯和次世代定序(NGS)等新穎和先進技術的出現也增加了對用於工作流程最佳化的整合設備、軟體和服務解決方案的需求。

本研究調查了驅動和限制生命科學設備和研究工具產業成長的因素。應用領域包括學術和政府使用、臨床診斷、製藥和生物技術。包含來自北美、歐洲、亞太地區 (APAC)、拉丁美洲以及中東、非洲和南亞 (MEASA)的案例研究。它還透過評估行業細分、法規環境和新興經營模式以及市場收益和預測來確定行業提供的關鍵成長機會。

目錄

生命科學設備和研究工具的改造

  • 為什麼成長如此困難?
  • The Strategic Imperative 8(TM)
  • 關鍵策略要務對生命科學設備和研究工具產業的影響

生態系統

  • 分析範圍
  • 分割
  • 定義
  • 競爭環境
  • 生命科學設備和研究工具的生態系統
  • 主要競爭對手

成長發電機

  • 成長指標
  • 生長促進因子
  • 成長抑制因素
  • 預測考慮因素
  • 收益預測
  • 收益預測分析
  • 價格趨勢和預測分析
  • 按產品分類的收益預測
  • 按產品分類的收入比例預測
  • 按產品分類的收益預測分析
  • 按技術分類的收益預測
  • 按技術分類的收入比例預測
  • 按技術分類的收益預測分析
  • 各行業收益預測
  • 各行業收入比例預測
  • 各行業收益預測分析
  • 按地區分類的收益預測
  • 各地區收入比例預測
  • 按地區分類的收益預測分析
  • 收益佔有率
  • 收益佔有率分析

生長發生器:NGS

  • 成長指標
  • 收益預測
  • 按地區分類的收益預測
  • 預測分析
  • 值得關注的主要企業

生長發生器:PCR

  • 成長指標
  • 收益預測
  • 按地區分類的收益預測
  • 預測分析
  • 值得關注的主要企業

生長發生器:微陣列

  • 成長指標
  • 收益預測
  • 按地區分類的收益預測
  • 預測分析
  • 值得關注的主要企業

生長發生器:流式細胞技術

  • 成長指標
  • 收益預測
  • 按地區分類的收益預測
  • 預測分析
  • 值得關注的主要企業

生長發生器:質譜法

  • 成長指標
  • 收益預測
  • 地區收益預測
  • 預測分析
  • 值得關注的主要企業

成長產生器:其他(分析化學、實驗室自動化、LIMS、資訊學、光譜學、材料分析、層析法)

  • 成長指標
  • 收益預測
  • 地區收益預測
  • 預測分析
  • 值得關注的主要企業

成長機會宇宙

  • 成長機會 1:用於 Hyplex 蛋白質體學的先進質譜工具
  • 成長機會 2:亞太地區臨床診斷實驗室自動化解決方案
  • 成長機會三:裝備器材電商經營模式
  • 電子商務模式採用的促進因素

最佳實踐意識

弗羅斯特雷達

下一步

簡介目錄
Product Code: KA5D-55

A Steady Increase in Laboratory Budgets in Academia is Driving Innovation

This study analyzes the life science instrumentation and research tools industry, covering the chemicals, consumables, instruments, reagents, suppliers, and IT solutions used in research laboratories. The global market for life science instrumentation and research tools is projected to experience steady growth from 2023 to 2029, achieving significant revenue milestones, driven largely by laboratory automation and software solutions. As life science research becomes more expensive and budgets more constrained, traditional sales approaches to instruments and equipment are proving inefficient. There is an urgent need for new business models that can provide access to novel technologies without necessitating the purchase of all the equipment. There is also a greater demand for integrated instruments, software, and service solutions for workflow optimization, driven by the emergence of novel and advanced technologies like advanced microscopy, gene editing, and next-generation sequencing (NGS).

This study examines the factors driving and restraining the growth of the life science instrumentation and research tools industry. Application areas include academic institutes and governmental uses, clinical diagnostics, pharmaceuticals, and biotechnology. This research offers case studies from North America, Europe, Asia-Pacific (APAC), Latin America, and the Middle East, Africa, and South Asia (MEASA). It also identifies the core growth opportunities presented by the industry by evaluating industry segments, the regulatory environment, and emerging business models, as well as market revenue and forecasts.

Table of Contents

Transformation in Life Science Instrumentation and Research Tools

  • Why is it Increasingly Difficult to Grow?
  • The Strategic Imperative 8™
  • The Impact of the Top 3 Strategic Imperatives on the Life Science Instrumentation and Research Tools Industry

Ecosystem

  • Scope of Analysis
  • Segmentation
  • Definitions
  • Competitive Environment
  • Life Science Instrumentation and Research Tools Ecosystem
  • Key Competitors

Growth Generator

  • Growth Metrics
  • Growth Drivers
  • Growth Restraints
  • Forecast Considerations
  • Revenue Forecast
  • Revenue Forecast Analysis
  • Pricing Trends and Forecast Analysis
  • Revenue Forecast by Product
  • Percent Revenue Forecast by Product
  • Revenue Forecast Analysis by Product
  • Revenue Forecast by Technology
  • Percent Revenue Forecast by Technology
  • Revenue Forecast Analysis by Technology
  • Revenue Forecast by Industry
  • Percent Revenue Forecast by Industry
  • Revenue Forecast Analysis by Industry
  • Revenue Forecast by Region
  • Percent Revenue Forecast by Region
  • Revenue Forecast Analysis by Region
  • Revenue Share
  • Revenue Share Analysis

Growth Generator: NGS

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Region
  • Forecast Analysis
  • Key Companies to Watch

Growth Generator: PCR

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Region
  • Forecast Analysis
  • Key Companies to Watch

Growth Generator: Microarrays

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Region
  • Forecast Analysis
  • Key Companies to Watch

Growth Generator: Flow Cytometry

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Region
  • Forecast Analysis
  • Key Companies to Watch

Growth Generator: Mass Spectrometry

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Region
  • Forecast Analysis
  • Key Companies to Watch

Growth Generator: Others-Analytical Chemicals, Lab Automation, LIMS, Informatics, Spectroscopy, Material Analysis, and Chromatography

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Region
  • Forecast Analysis
  • Key Companies to Watch

Growth Opportunity Universe

  • Growth Opportunity 1: Advanced Mass Spectrometry Tools for High-plex Proteomics
  • Growth Opportunity 2: Laboratory Automation Solutions for Clinical Diagnostics in APAC
  • Growth Opportunity 3: Growth Opportunity 3: eCommerce Business Model for Instruments and Equipment
  • Drivers for eCommerce Model Adoption

Best Practice Recognition

  • Best Practice Recognition

Frost Radar

  • Frost Radar

Next Steps

  • Benefits and Impacts of Growth Opportunities
  • Next Steps
  • Take the Next Step
  • List of Exhibits
  • Legal Disclaimer